These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
344 related articles for article (PubMed ID: 12664551)
1. [Investigation of the activity of the preparation cerbiden against Candida spp]. Hladun NP; Bondarenko AS; Nahorna SS; Smyrnova OV Mikrobiol Z; 2002; 64(6):57-61. PubMed ID: 12664551 [TBL] [Abstract][Full Text] [Related]
2. In vitro antifungal activity of phenylheptatriyne from Bidens cernua L. against yeasts. Rybalchenko NP; Prykhodko VA; Nagorna SS; Volynets NN; Ostapchuk AN; Klochko VV; Rybalchenko TV; Avdeeva LV Fitoterapia; 2010 Jul; 81(5):336-8. PubMed ID: 19837144 [TBL] [Abstract][Full Text] [Related]
3. [Study of the cerbiden spectrum of antifungal activity against fungi pathogenic to humans]. Smirnov VV; Hladun NP; Bondarenko AS; Hahorna SS; Zakharchenko VO Mikrobiol Z; 2003; 65(3):70-7. PubMed ID: 12945196 [TBL] [Abstract][Full Text] [Related]
4. [Antifungal activity of the components of the drug cerbiden of plant origin]. Smirnov VV; Bondarenko AS; Gladun NP Mikrobiol Z; 2003; 65(4):17-22. PubMed ID: 14618782 [TBL] [Abstract][Full Text] [Related]
5. In vitro antifungal sensitivity of fluconazole, clotrimazole and nystatin against vaginal candidiasis in females of childbearing age. Khan F; Baqai R J Ayub Med Coll Abbottabad; 2010; 22(4):197-200. PubMed ID: 22455297 [TBL] [Abstract][Full Text] [Related]
6. In vitro activity of clotrimazole for Candida strains isolated from recent patient samples. Schmidt A Arzneimittelforschung; 1995 Dec; 45(12):1338-40. PubMed ID: 8595097 [TBL] [Abstract][Full Text] [Related]
7. In vitro antifungal susceptibility of clinical isolates of Candida spp. obtained from patients with different predisposing factors to candidosis. Pinto PM; Weikert-Oliveira Rde C; Lyon JP; Cury VF; Arantes RR; Koga-Ito CY; Resende MA Microbiol Res; 2008; 163(5):579-85. PubMed ID: 16962755 [TBL] [Abstract][Full Text] [Related]
8. Susceptibilities to amphotericin B and fluconazole of Candida species in Taiwan Surveillance of Antimicrobial Resistance of Yeasts 2006. Yang YL; Wang AH; Wang CW; Cheng WT; Li SY; Lo HJ; Diagn Microbiol Infect Dis; 2008 Jun; 61(2):175-80. PubMed ID: 18304773 [TBL] [Abstract][Full Text] [Related]
9. In vitro susceptibility and resistance of Candida spp. to hamycin. Athar MA Sabouraudia; 1971 Nov; 9(3):256-62. PubMed ID: 4944203 [No Abstract] [Full Text] [Related]
10. Survey of amphotericin B susceptibility of Candida clinical isolates determined by Etest. Chiu YS; Chang SC; Hsueh PR; Wang JL; Sun HY; Chen YC J Microbiol Immunol Infect; 2006 Aug; 39(4):335-41. PubMed ID: 16926981 [TBL] [Abstract][Full Text] [Related]
11. Community-acquired fungemia due to a multiple-azole-resistant strain of Candida tropicalis. Jandourek A; Brown P; Vazquez JA Clin Infect Dis; 1999 Dec; 29(6):1583-4. PubMed ID: 10585825 [No Abstract] [Full Text] [Related]
12. Susceptibilities to amphotericin B and fluconazole of Candida species in TSARY 2002. Yang YL; Li SY; Cheng HH; Lo HJ; Diagn Microbiol Infect Dis; 2005 Mar; 51(3):179-83. PubMed ID: 15766603 [TBL] [Abstract][Full Text] [Related]
13. In vitro susceptibility testing of Candida and Aspergillus spp. to voriconazole and other antifungal agents using Etest: results of a French multicentre study. Mallié M; Bastide JM; Blancard A; Bonnin A; Bretagne S; Cambon M; Chandenier J; Chauveau V; Couprie B; Datry A; Feuilhade M; Grillot R; Guiguen C; Lavarde V; Letscher V; Linas MD; Michel A; Morin O; Paugam A; Piens MA; Raberin H; Tissot E; Toubas D; Wade A Int J Antimicrob Agents; 2005 Apr; 25(4):321-8. PubMed ID: 15784312 [TBL] [Abstract][Full Text] [Related]
15. In vitro susceptibility of oral Candida to seven antifungal agents. Kuriyama T; Williams DW; Bagg J; Coulter WA; Ready D; Lewis MA Oral Microbiol Immunol; 2005 Dec; 20(6):349-53. PubMed ID: 16238594 [TBL] [Abstract][Full Text] [Related]
16. In vitro activity of 2-cyclohexylidenhydrazo-4-phenyl-thiazole compared with those of amphotericin B and fluconazole against clinical isolates of Candida spp. and fluconazole-resistant Candida albicans. De Logu A; Saddi M; Cardia MC; Borgna R; Sanna C; Saddi B; Maccioni E J Antimicrob Chemother; 2005 May; 55(5):692-8. PubMed ID: 15772140 [TBL] [Abstract][Full Text] [Related]
17. [In vitro susceptibility of vaginal isolates of Candida vs clotrimazole and nystatin]. Suárez VL; Fernández Andreu CM Rev Cubana Med Trop; 2003; 55(3):138-45. PubMed ID: 15849917 [TBL] [Abstract][Full Text] [Related]
18. In vitro activity of 6 antifungal agents on candida species isolated as causative agents from vaginal and other clinical specimens. Ellabib MS; ElJariny IA Saudi Med J; 2001 Oct; 22(10):860-3. PubMed ID: 11744942 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of the etest method using Mueller-Hinton agar with glucose and methylene blue for determining amphotericin B MICs for 4,936 clinical isolates of Candida species. Pfaller MA; Boyken L; Messer SA; Tendolkar S; Hollis RJ; Diekema DJ J Clin Microbiol; 2004 Nov; 42(11):4977-9. PubMed ID: 15528683 [TBL] [Abstract][Full Text] [Related]
20. In vitro susceptibility profile of 200 recent clinical isolates of Candida spp. to topical antifungal treatments of vulvovaginal candidiasis, the imidazoles and nystatin agents. Choukri F; Benderdouche M; Sednaoui P J Mycol Med; 2014 Dec; 24(4):303-7. PubMed ID: 25442913 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]